GLP-1 Medication Prices in India: Updated July 2026
Every GLP-1 medication legally sold in India, with per-dose and per-month costs in one table. Verified against official MRPs and updated monthly, because pricing in this market changes faster than most articles do.
ALTRcare Medical Team
Clinical Editorial
As of July 2026, GLP-1 medication in India costs anywhere from ₹1,290 a month for a generic semaglutide vial to ₹25,781 a month for the highest dose of tirzepatide (Mounjaro or Yurpeak). Between those extremes sit Alkem's Semasize at ₹1,800, Ozempic and Wegovy from roughly ₹5,660 after Novo Nordisk's April 2026 price cut, and oral Rybelsus at around ₹8,900 to ₹10,900. This page holds the full table, verified against official maximum retail prices, and is updated monthly.
Prices last verified: 24 July 2026
Figures below are India MRPs or manufacturer-announced launch prices, not imported or grey-market quotes. Pharmacy discounts of 10 to 15 percent off MRP are common. If a figure looks stale, the market probably moved again; this page is revised every month.
The full price table (July 2026)
| Medication | Molecule | Format | Per dose | Per month |
|---|---|---|---|---|
| Generic semaglutide (Natco Semanat, Glenmark GLIPIQ) | Semaglutide | Multi-dose vial, weekly injection | From ₹325 | From ₹1,290 |
| Semasize (Alkem) | Semaglutide | Pre-filled disposable pen, 4 doses; reusable pen for higher doses | From ₹450 | From ₹1,800 |
| Other generic pens (Zydus, Sun Pharma, Dr. Reddy's Obeda) | Semaglutide | Pre-filled pen, weekly injection | ₹550 to ₹2,000 | ₹2,200 to ₹8,000 |
| Ozempic (Novo Nordisk) | Semaglutide | Pre-filled pen, weekly injection | From ₹1,415 | ₹5,660 (0.25 mg starter) to roughly ₹16,000 at maintenance |
| Wegovy (Novo Nordisk) | Semaglutide | FlexTouch pen, weekly injection | From ₹1,415 | ₹5,660 (0.25 mg) to ₹16,400 (2.4 mg) |
| Rybelsus (Novo Nordisk) | Semaglutide (oral) | Daily tablet, strips of 10 | ₹297 to ₹365 per tablet | Roughly ₹8,900 to ₹10,900 |
| Mounjaro (Eli Lilly) | Tirzepatide | Vial or KwikPen, weekly injection | ₹3,281 (2.5 mg) to ₹6,445 (15 mg) | ₹13,125 to ₹25,781 |
| Yurpeak (Cipla, made by Eli Lilly) | Tirzepatide | KwikPen only, six strengths | Same as Mounjaro | ₹13,125 to ₹25,781 |
Why the range is so wide
One event explains most of this table: on 20 March 2026, Novo Nordisk's semaglutide patent expired in India. More than 40 Indian companies launched DCGI-approved versions of the same molecule within weeks, and prices for semaglutide collapsed from ₹10,000-plus a month to as little as ₹1,290. Novo Nordisk responded by cutting Ozempic and Wegovy prices sharply in April 2026. Tirzepatide is the exception: Eli Lilly's patents on it run well into the 2030s, so Mounjaro and Yurpeak face no generic competition and their prices have held.
Semaglutide prices in detail
| Brand | Maker | Monthly cost | Notes |
|---|---|---|---|
| Semanat (vial) | Natco | From ₹1,290 | Cheapest entry point; vial and syringe, not a pen |
| GLIPIQ | Glenmark | From ₹1,300 | ₹325 per weekly dose |
| Semasize / Obesema / Hepaglide | Alkem | From ₹1,800 | Disposable 4-dose pen; reusable pen cuts cost at higher doses |
| Semaglyn | Zydus | About ₹2,200 | Pen format |
| Noveltreat / Sematrinity | Sun Pharma | ₹3,000 to ₹8,000 | Weight-management and diabetes labels respectively |
| Obeda | Dr. Reddy's | About ₹4,200 | Pen; Indian Phase 3 dataset |
| Ozempic | Novo Nordisk | ₹5,660 to ~₹16,000 | Diabetes label; price cut April 2026 |
| Wegovy | Novo Nordisk | ₹5,660 to ₹16,400 | Obesity label; 2.4 mg is the full maintenance dose |
Tirzepatide prices in detail
| Weekly dose | Per dose | Per month (4 doses) |
|---|---|---|
| 2.5 mg (starter) | ₹3,281 | ₹13,125 |
| 5 mg | ₹4,101 | ₹16,404 |
| 7.5 mg and 10 mg | About ₹5,156 | About ₹20,625 |
| 12.5 mg and 15 mg | About ₹6,445 | About ₹25,781 |
Want the medicine plus the doctor, in one price?
ALTRcare programs start at ₹3,499 a month for doctor-led semaglutide and ₹13,999 a month for Yurpeak (tirzepatide), covering medication, consultations, titration and follow-up together. Take the free 2-minute assessment to see what fits.
What the drug price does not include
Every figure above is the medicine alone. Used properly, a GLP-1 also needs a prescribing doctor, baseline and follow-up blood tests, a titration plan, and someone to call when the nausea week hits. Bought separately, that adds ₹2,000 to ₹5,000 a month in most cities. This is why comparing a bare pharmacy MRP against an all-inclusive program price misleads in both directions: the vial is cheaper than it looks risky, and the program is cheaper than it looks expensive.
If a price looks too good, check the source
Prices meaningfully below this table usually mean grey-market imports, compounded or research-grade peptides, or counterfeit pens. Every legal GLP-1 in India is prescription-only and sold through licensed pharmacies.
Key takeaways
- Generic semaglutide starts at ₹1,290 a month; Alkem's Semasize pen starts at ₹1,800.
- Ozempic and Wegovy start around ₹5,660 a month after the April 2026 price cut, rising to ₹16,000-plus at maintenance doses.
- Tirzepatide (Mounjaro and Yurpeak) runs ₹13,125 to ₹25,781 a month and has no generic competition until well into the 2030s.
- Rybelsus, the daily oral semaglutide, costs roughly ₹8,900 to ₹10,900 a month.
- All of these are prescription medicines; the drug price excludes doctor fees and blood tests.
Frequently asked questions
What is the cheapest GLP-1 medication in India in 2026?
Generic semaglutide vials (Natco Semanat, Glenmark GLIPIQ) start at about ₹1,290 per month, or ₹325 per weekly injection. The cheapest pen format is Alkem's Semasize at ₹1,800 per month.
How much does tirzepatide cost per month in India?
Mounjaro and Yurpeak both cost ₹13,125 per month at the 2.5 mg starting dose, rising to about ₹25,781 per month at the 12.5 to 15 mg doses. Both brands are made by Eli Lilly and priced identically.
Did Ozempic and Wegovy prices drop in India?
Yes. Novo Nordisk cut Wegovy prices by up to 37 percent in November 2025 and cut again in April 2026 after generic semaglutide launched. Both now start around ₹5,660 per month at the 0.25 mg starter dose.
Why is there no generic tirzepatide in India?
Eli Lilly's tirzepatide patents in India run well into the 2030s, unlike semaglutide, whose patent expired on 20 March 2026. Until then, Mounjaro and Yurpeak are the only legal tirzepatide brands.
Are these prices per dose or per month?
The table shows both. Injectable GLP-1s are taken once a week, so a month is four doses. Rybelsus is a daily tablet, so a month is about 30 tablets.
Ready to take the next step?
Take the free 2-minute eligibility assessment. A doctor reviews it before anything is prescribed — no obligation.
This article is for general educational purposes and is not a substitute for personalised medical advice. GLP-1 medications are prescription-only and not suitable for everyone. Always consult a qualified doctor before starting, changing, or stopping any treatment.
